Partnerships are integral to Harbour BioMed's strategy to build a fully integrated biopharmaceutical company. The company has entered into several co-discovery agreements to expand its portfolio and has also signed license agreements for its transgenic mouse platforms with select partners to further Next-Gen drug invention.
友情链接:腾博会娱乐  利来w66官网app  ag88环亚集团旗舰  环亚ag自营厅  四虎在线观看网站  ag88环亚国际厅  AG88环亚集团国际厅客户端  皇家真人娱乐平台